Trademark/Service Mark Application, Principal Register
PTO- 1478
Approved for use through 10/31/2024. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number
Trademark/Service Mark Application, Principal Register
The mark consists of standard characters, without claim to any particular font style, size, or color.
REGISTER
Principal
APPLICANT INFORMATION
*OWNER OF MARK
SpringWorks Therapeutics Operating Company, Inc.
*MAILING ADDRESS
100 Washington Blvd
*CITY
Stamford
*STATE
(Required for U.S. applicants)
Connecticut
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY
United States
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
06902
*EMAIL ADDRESS
XXXX
LEGAL ENTITY INFORMATION
TYPE
corporation
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY OF INCORPORATION
Delaware
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS
005
*IDENTIFICATION
Pharmaceutical preparations for human use for the treatment of oncology, neuro-oncology, tumors, cancer, and rare diseases; pharmaceutical
preparations for human use for the treatment of neurofibromatosis; small molecule therapeutic preparations for human use for the treatment of oncology, neuro-oncology, tumors, cancer, and rare
diseases; small molecule therapeutic preparations for human use for the treatment of neurofibromatosis
Approved for use through 10/31/2024. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number
Trademark/Service Mark Application, Principal Register
Serial Number:98040834
Filing Date:06/13/2023
To the Commissioner for Trademarks:
MARK: EZMEKLY (Standard Characters, see mark)
The literal element of the mark consists of EZMEKLY. The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, SpringWorks Therapeutics Operating Company, Inc., a corporation of Delaware, having an address of
100 Washington Blvd
Stamford, Connecticut 06902
United States
XXXX
requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C.
Section 1051 et seq.), as amended, for the following:
International Class 005: Pharmaceutical preparations for human use for the treatment of oncology, neuro-oncology, tumors, cancer, and rare diseases; pharmaceutical preparations for human use
for the treatment of neurofibromatosis; small molecule therapeutic preparations for human use for the treatment of oncology, neuro-oncology, tumors, cancer, and rare diseases; small molecule
therapeutic preparations for human use for the treatment of neurofibromatosis
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.
The owner's/holder's proposed attorney information: Danny M. Awdeh. Other appointed attorneys are Laura Johnson and all other attorneys of Finnegan, Henderson, Farabow, Garrett & Dunner
LLP. Danny M. Awdeh of Finnegan, Henderson, Farabow, Garrett & Dunner LLP, is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, and the attorney(s) is located
at
901 New York Avenue NW
Washington, District of Columbia 20001
United States
202-408-4000(phone)
docketing@finnegan.com
The docket/reference number is 157852.0050.
Danny M. Awdeh submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any U.S.
Commonwealth or territory.
The applicant's current Correspondence Information:
Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed,
and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $350 has been submitted with the application, representing payment for 1 class(es).
Declaration
Declaration Signature
Signature: /Michael Ciraolo/ Date: 06/13/2023
Signatory's Name: Michael Ciraolo
Signatory's Position: Vice President, Intellectual Property
Signatory's Phone Number: 202-408-4000
Signature method: Sent to third party for signature
Payment Sale Number: 98040834
Payment Accounting Date: 06/13/2023
Serial Number: 98040834
Internet Transmission Date: Tue Jun 13 17:39:25 ET 2023
TEAS Stamp: USPTO/BAS-XX.XXX.X.X-2023061317392670019
4-98040834-8609fe7242fac22ce56c724ece9d9
a2dd5b18d175e783dcb963b49b7d96de27a-CC-3
9259926-20230613135651079879